PAVM
PAVmed Inc

8,835
Mkt Cap
$9.28M
Volume
858,069.00
52W High
$1.25
52W Low
$0.304
PE Ratio
0.37
PAVM Fundamentals
Price
$0.4107
Prev Close
$0.4292
Open
$0.4071
50D MA
$0.4549
Beta
1.25
Avg. Volume
224,133.05
EPS (Annual)
$0.4961
P/B
0.67
Rev/Employee
$76,794.87
Loading...
Loading...
News
all
press releases
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit PR Newswire NEW YORK, Oct. 15, 2025 NEW YORK, Oct. 15, 2025...
PR Newswire·9d ago
News Placeholder
More News
News Placeholder
PAVmed (PAVM) Upgraded to Strong Buy: Here's Why
PAVmed (PAVM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Zacks·14d ago
News Placeholder
Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement
Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire NEW YORK, Feb. 25, 2025 NEW...
PR Newswire·8mo ago
News Placeholder
PAVmed and Subsidiary Veris Health Complete Private Placement Financing
PAVmed and Subsidiary Veris Health Complete Private Placement Financing PAVmed and Subsidiary Veris Health Complete Private Placement Financing PR Newswire NEW YORK, Feb. 24, 2025 Gross proceeds of...
PR Newswire·8mo ago
News Placeholder
Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health
Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health PR Newswire NEW YORK, Feb. 20, 2025 LEAA...
PR Newswire·8mo ago
News Placeholder
PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement
PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement PR Newswire NEW YORK, Feb. 18, 2025 NEW YORK, Feb. 18...
PR Newswire·8mo ago
News Placeholder
Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital...
PR Newswire·9mo ago
News Placeholder
Lucid Diagnostics Announces Record Quarterly EsoGuard Test Volume
Lucid Diagnostics Announces Record Quarterly EsoGuard Test Volume Lucid Diagnostics Announces Record Quarterly EsoGuard Test Volume PR Newswire NEW YORK, Jan. 13, 2025 Quarterly test volume of over...
PR Newswire·9mo ago
News Placeholder
Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid...
PR Newswire·10mo ago
News Placeholder
Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters
Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for...
PR Newswire·10mo ago

Latest PAVM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.